- Report
- April 2024
- 142 Pages
Global
From €7558EUR$7,950USD£6,349GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €1426EUR$1,500USD£1,198GBP
- Report
- November 2023
- 139 Pages
Global
From €4230EUR$4,450USD£3,554GBP
- Report
- January 2024
- 395 Pages
Global
From €7130EUR$7,500USD£5,990GBP
- Report
- August 2022
- 117 Pages
Global
From €4278EUR$4,500USD£3,594GBP
- Report
- January 2024
- 144 Pages
Global
From €4040EUR$4,250USD£3,394GBP
- Report
- June 2023
- 104 Pages
Global
From €4230EUR$4,450USD£3,554GBP
- Report
- July 2023
- 140 Pages
Global
From €4705EUR$4,949USD£3,952GBP
- Report
- March 2023
- 203 Pages
Global
From €3422EUR$3,600USD£2,875GBP
- Report
- March 2023
- 84 Pages
Africa, Middle East
From €1426EUR$1,500USD£1,198GBP
- Report
- March 2023
- 84 Pages
Asia Pacific
From €1426EUR$1,500USD£1,198GBP
- Report
- March 2023
- 85 Pages
Europe
From €1426EUR$1,500USD£1,198GBP
- Report
- March 2023
- 74 Pages
North America
From €1426EUR$1,500USD£1,198GBP
- Report
- January 2024
- 95 Pages
United States
€3327EUR$3,500USD£2,795GBP
- Report
- May 2023
- 146 Pages
Global
From €3500EUR$3,944USD£3,043GBP
- Report
- November 2021
- 600 Pages
Global
From €3803EUR$4,000USD£3,195GBP
- Book
- July 2023
- 1568 Pages
- Book
- July 2009
- 1116 Pages

Gabapentin is a medication used to treat certain types of seizures and nerve pain. It is a central nervous system (CNS) drug, meaning it acts on the brain and spinal cord to produce its effects. It is used to treat epilepsy, neuropathic pain, hot flashes, and restless leg syndrome. It is also used off-label to treat anxiety and insomnia. Gabapentin is generally well-tolerated, but can cause side effects such as dizziness, drowsiness, and confusion.
Gabapentin is available in both generic and brand-name forms. It is available in capsule, tablet, and oral solution forms. It is also available as an extended-release tablet, which is taken once daily.
The market for Gabapentin is highly competitive, with many companies offering generic and brand-name versions of the drug. Some of the companies in the market include Pfizer, Mylan, Teva Pharmaceuticals, Sun Pharmaceuticals, and Lupin Pharmaceuticals. Show Less Read more